Mesoblast Limited (MESO) Q2 2026 Earnings Call Transcript
Source: SeekingAlpha
2026-02-27 02:27:52 ET
Mesoblast Limited (MESO) Q2 2026 Earnings Call February 26, 2026 5:00 PM EST
Company Participants
Paul Hughes - Joint Company Secretary
Silviu Itescu - Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director
James O’Brien - Chief Financial Officer
Marcelo Santoro - Chief Commercial Officer
...
Read the full article on Seeking Alpha
For further details see:
Mesoblast Limited (MESO) Q2 2026 Earnings Call Transcript
Mesoblast Ltd Ord
NASDAQ: MEOBF
MEOBF Trading
0.0% G/L:
$1.55 Last:
2,000 Volume:
$1.55 Open:
MEOBF Latest News
MEOBF Stock Data
$2,165,966,075
573,072,937
N/A
91
N/A
Biotechnology & Life Sciences
Healthcare
AU
Melbourne
